Published May 2022
Abstract:
The COVID-19 pandemic created an unprecedented strain on the global healthcare system and led to an urgent need for access to health products. However, the scarcity of alternative supplies and materials puts a burden on pharmaceutical companies.
This white paper explores:
Keywords: API, regulations, supply chain, manufacturing, biotechnology, covid-19, pandemic, API, PQS, quality, supplier capability
Click here to view White paper: 11 Tips on Supply Chain Management Post Covid